0001213900-23-086163.txt : 20231113 0001213900-23-086163.hdr.sgml : 20231113 20231113163020 ACCESSION NUMBER: 0001213900-23-086163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231108 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Runge Jeffrey W. CENTRAL INDEX KEY: 0001479091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39336 FILM NUMBER: 231399298 MAIL ADDRESS: STREET 1: C/O PHARMATHENE, INC., ONE PARK PLACE STREET 2: SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aditxt, Inc. CENTRAL INDEX KEY: 0001726711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823204328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 737 N. FIFTH STREET, SUITE 200 CITY: RICHMOND STATE: VA ZIP: 23219 BUSINESS PHONE: 909-488-0844 MAIL ADDRESS: STREET 1: 737 N. FIFTH STREET, SUITE 200 CITY: RICHMOND STATE: VA ZIP: 23219 FORMER COMPANY: FORMER CONFORMED NAME: Aditx Therapeutics, Inc. DATE OF NAME CHANGE: 20201113 FORMER COMPANY: FORMER CONFORMED NAME: ADiTx Therapeutics, Inc. DATE OF NAME CHANGE: 20171229 4 1 ownership.xml X0508 4 2023-11-08 0 0001726711 Aditxt, Inc. ADTX 0001479091 Runge Jeffrey W. C/O ADITXT, INC. 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 1 0 0 0 0 Options (right to buy) 5.01 2023-11-08 4 A 0 470 0 A 2033-11-08 Common Stock 470 470 D On November 8, 2023, the Reporting Person was granted options ("Options") to purchase up to 470 shares of the Registrant's common stock pursuant to the Registrant's 2021 Omnibus Equity Incentive Plan. The Options vest fully on the date of grant. /s/ Jeffrey Runge 2023-11-13